Preservation of Lung Function with Tocilizumab in Patients with Systemic Sclerosis Interstitial Lung Disease: Analysis from the Double-Blind Period of a Phase 3 Trial | Zendy

AI Assistant Blog Pricing

Preservation of Lung Function with Tocilizumab in Patients with Systemic Sclerosis Interstitial Lung Disease: Analysis from the Double-Blind Period of a Phase 3 Trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.